New EMA Head To Bolster Regulatory Collaboration In The EU & Beyond
Strengthening regulatory partnerships and being ready to support the translation of disruptive innovations into the treatments of tomorrow are on the to-do list of incoming European Medicines Agency chief Emer Cooke.
You may also be interested in...
Pfizer has been unsuccessful in its appeal against the health technology assessment body’s rejection of the rare heart disease drug, Vyndaqel. Meanwhile, Dr Falk Pharma has received the all-clear to make Jorveza (budesonide) available on the National Health Service for eosinophilic esophagitis.
A study examining 27 drug marketing applications that contained real world data and an idea on how to make it easier for companies to understand which RWD to use were discussed this week at the RAPS EURO Convergence 2021 conference.
Vertex and CRISPR can now get access to the advantages afforded by the European Medicines Agency’s priority medicines scheme for both of the indications they are targeting with their investigational gene therapy, CTX001.